FolioLanternBeta
ROIVRoivant Sciences Ltd.

Melissa Epperly

Director at Roivant Sciences Ltd., as of Oct 5, 2026Sold $2.6M of stock in the past 12 months: 55% under a disclosed plan and 45% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
15K
shares held after the latest filing, Roivant Sciences Ltd.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
82K
shares sold, past 12 months
4
days with sales
$1.2M
largest single day, Mar 16, 2026
1
company filed for

Share of stake sold at Roivant Sciences Ltd. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $1.2M no plan disclosed$1.2MMarAprMayJun 2026: $610K under a disclosed planJunJulAugSep 2026: $196K under a disclosed planSepOct 2026: $641K under a disclosed planOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Roivant Sciences Ltd. (ROIV)DirectorJul 25, 2022Oct 5, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.